202 related articles for article (PubMed ID: 15007093)
21. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
[TBL] [Abstract][Full Text] [Related]
22. PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression.
Chen NG; Sarabia SF; Malloy PJ; Zhao XY; Feldman D; Reaven GM
Biochem Biophys Res Commun; 1999 Oct; 263(3):718-22. PubMed ID: 10512746
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
Ma LJ; Marcantoni C; Linton MF; Fazio S; Fogo AB
Kidney Int; 2001 May; 59(5):1899-910. PubMed ID: 11318962
[TBL] [Abstract][Full Text] [Related]
25. Lysophosphatidic acid reduces the organ injury caused by endotoxemia-a role for G-protein-coupled receptors and peroxisome proliferator-activated receptor-gamma.
Murch O; Collin M; Thiemermann C
Shock; 2007 Jan; 27(1):48-54. PubMed ID: 17172980
[TBL] [Abstract][Full Text] [Related]
26. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
[TBL] [Abstract][Full Text] [Related]
27. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation.
Subramanian P; Karshovska E; Reinhard P; Megens RT; Zhou Z; Akhtar S; Schumann U; Li X; van Zandvoort M; Ludin C; Weber C; Schober A
Circ Res; 2010 Jul; 107(1):96-105. PubMed ID: 20360252
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
[TBL] [Abstract][Full Text] [Related]
29. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
[TBL] [Abstract][Full Text] [Related]
30. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells.
Iijima K; Yoshizumi M; Ako J; Eto M; Kim S; Hashimoto M; Sugimoto N; Liang YQ; Sudoh N; Toba K; Ouchi Y
Biochem Biophys Res Commun; 1998 Jun; 247(2):353-6. PubMed ID: 9642130
[TBL] [Abstract][Full Text] [Related]
31. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma.
Han KH; Chang MK; Boullier A; Green SR; Li A; Glass CK; Quehenberger O
J Clin Invest; 2000 Sep; 106(6):793-802. PubMed ID: 10995790
[TBL] [Abstract][Full Text] [Related]
32. Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages.
Iwashima Y; Eto M; Hata A; Kaku K; Horiuchi S; Ushikubi F; Sano H
Biochem Biophys Res Commun; 2000 Oct; 277(2):368-80. PubMed ID: 11032732
[TBL] [Abstract][Full Text] [Related]
33. Plasticity-related gene-1 inhibits lysophosphatidic acid-induced vascular smooth muscle cell migration and proliferation and prevents neointima formation.
Gaaya A; Poirier O; Mougenot N; Hery T; Atassi F; Marchand A; Saulnier-Blache JS; Amour J; Vogt J; Lompré AM; Soubrier F; Nadaud S
Am J Physiol Cell Physiol; 2012 Nov; 303(10):C1104-14. PubMed ID: 23015549
[TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.
Siess W; Zangl KJ; Essler M; Bauer M; Brandl R; Corrinth C; Bittman R; Tigyi G; Aepfelbacher M
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6931-6. PubMed ID: 10359816
[TBL] [Abstract][Full Text] [Related]
35. Farnesyl phosphates are endogenous ligands of lysophosphatidic acid receptors: inhibition of LPA GPCR and activation of PPARs.
Liliom K; Tsukahara T; Tsukahara R; Zelman-Femiak M; Swiezewska E; Tigyi G
Biochim Biophys Acta; 2006 Dec; 1761(12):1506-14. PubMed ID: 17092771
[TBL] [Abstract][Full Text] [Related]
36. Sensing environmental lipids by dendritic cell modulates its function.
Coutant F; Agaugué S; Perrin-Cocon L; André P; Lotteau V
J Immunol; 2004 Jan; 172(1):54-60. PubMed ID: 14688309
[TBL] [Abstract][Full Text] [Related]
37. Lysophosphatidic acid enhances neointimal hyperplasia following vascular injury through modulating proliferation, autophagy, inflammation and oxidative stress.
Shen X; Zou J; Li F; Zhang T; Guo T
Mol Med Rep; 2018 Jul; 18(1):87-96. PubMed ID: 29749484
[TBL] [Abstract][Full Text] [Related]
38. Lysophospholipid-Related Diseases and PPARγ Signaling Pathway.
Tsukahara T; Matsuda Y; Haniu H
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258184
[TBL] [Abstract][Full Text] [Related]
39. Lysophosphatidic acid signaling regulates the KLF9-PPARγ axis in human induced pluripotent stem cell-derived neurons.
Tsukahara T; Yamagishi S; Matsuda Y; Haniu H
Biochem Biophys Res Commun; 2017 Sep; 491(1):223-227. PubMed ID: 28716732
[TBL] [Abstract][Full Text] [Related]
40. Induction of CD36 by all-trans retinoic acid: retinoic acid receptor signaling in the pathogenesis of atherosclerosis.
Wuttge DM; Romert A; Eriksson U; Törmä H; Hansson GK; Sirsjö A
FASEB J; 2001 May; 15(7):1221-3. PubMed ID: 11344094
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
